Adrenomedullin ameliorates the development of atherosclerosis in apoE-/- mice

Peptides

Volumn 31, Issue 6, 2010, Pages 1150-1158

  Pan, Chun Shui ^a   Zhang, Jing ^c   Yu, Fang ^b   Teng, Xu ^a   Cao, Chang Qi ^a   Wu, Wei ^a   Tang, Chao Shu ^a,b   Qi, Yong Fen ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Adrenomedullin; ApoE mice; Atherosclerosis; Calcitonin receptor like receptor; Receptor activity modifying proteins

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; APOLIPOPROTEIN E; CALCITONIN RECEPTOR LIKE RECEPTOR; MESSENGER RNA; RECEPTOR ACTIVITY MODIFYING PROTEIN;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ASCENDING AORTA; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; HYPERLIPIDEMIA; MALE; MOUSE; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADRENOMEDULLIN; ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; DIET, ATHEROGENIC; DYSLIPIDEMIAS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CALCITONIN; RECEPTORS, PEPTIDE; RNA, MESSENGER;

MUS;

EID: 77952111526     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2010.03.005     Document Type: Article

References (41)

1. Beltoushi J., and Jamroz A. Adrenomedullin-what we know 10 years since its discovery?. Pol J Pharmacol 56 (2004) 5-27
2. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
3. Cueille C., Birot O., Bigard X., Hagner S., and Garel J.M. Post-transcriptional regulation of CRLR expression during hypoxia. Biochem Biophys Res Commun 326 (2005) 23-29
4. Eto T., Kato J., and Kitamura K. Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regul Pept 112 (2003) 61-69
5. Fukai N., Shichiri M., Ozawa N., Matsushita M., and Hirata Y. Coexpression of calcitonin receptor-like receptor and receptor activity-modifying protein 2 or 3 mediates the antimigratory effect of adrenomedullin. Endocrinology 144 (2003) 447-453
6. Gibbons C., Dackor R., Dunworth W., Fritz-Six K., and Caron K.M. Receptor activity-modifying proteins: "RAMP"ing up adrenomedullin signaling. Mol Endocrinol 21 (2007) 783-796
7. Hinson J.P., Kapas S., and Smith D.M. Adrenomedullin: a multifunctional regulatory peptide. Endocrine Review 21 (2000) 138-167
8. Horio T., Kohno M., Kano H., Ikeda M., Yasunari K., Yokokawa K., et al. Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res 77 (1995) 660-664
9. Huang Z., Li J., Jiang Z., Qi Y., Tang C., and Du J. Effects of adrenomedullin, C-type natriuretic peptide, and parathyroid hormone-related peptide on calcification in cultured rat vascular smooth muscle cells. J Cardiovasc Pharmacol 42 (2003) 89-97
10. Ignarro L.J., and Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Diab Rep 5 (2005) 17-23
11. Imai Y., Shindo T., Maemura K., Sata M., Saito Y., Kurihara Y., et al. Resistance to neointimal hyperplasia and fatty streak formation in mice with adrenomedullin overexpression. Arterioscler Thromb Vasc Biol 22 8 (2002) 1310-1315
12. Ishimitsu T., Ono H., Minami J., and Matsuoka H. Pathophysiologic and therapeutic implications of adrenomedullin in cardiovascular disorders. Pharmacol Ther 111 (2006) 909-927
13. Jiang W., Yang J.H., Wang S.H., Pan C.S., Qi Y.F., Zhao J., et al. Effects of adrenomedullin on aldosterone-induced cell proliferation in rat cardiac fibroblasts. Biochim Biophys Acta 1690 (2004) 265-275
14. Kampus P., Kals J., Ristimäe T., Muda P., Ulst K., Zilmer K., et al. Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein and oxidized low-density lipoprotein. J Hypertens 25 (2007) 819-825
15. Kato H., Shichiri M., Marumo F., and Hirata Y. Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 138 (1997) 2615-2620
16. Kato J., Tsuruda T., Kita T., Kitamura K., and Eto T. Adrenomedullin: a protective factor for blood vessels. Arterioscler Thromb Vasc Biol 25 (2005) 2480-2487
17. Kuzuya M., Nakamura K., Sasaki T., Cheng X.W., Itohara S., and Iguchi A. Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler Thromb Vasc Biol 26 (2006) 1120-1125
18. Libby P. Atherosclerosis: disease biology affecting the coronary vasculature. Am J Cardiol 98 (2006) 3Q-9Q
19. Liu N., Chen G., Wang X., Yao X., Su J., Li T., et al. Effects of certain vasoactive peptides on pathogenesis of vascular restenosis. Chin Med Sci J 18 (2003) 1-8
20. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393 (1998) 333-339
21. Mishima K., Kato J., and Kuwasako K. Effects of endothelin on adrenomedullin secretion and expression of adrenomedullin receptors in rat cardiomyocytes. Biochem Biophys Res Commun 287 (2001) 264-269
22. Mishima K., Kato J., Kuwasako K., Imamura T., Kitamura K., and Eto T. Angiotensin II modulates gene expression of adrenomedullin receptor components in rat cardiomyocytes. Life Sci 73 (2003) 1629-1635
23. Nakayama M., Takahashi K., Murakami O., Murakami H., Sasano H., Shirato K., et al. Adrenomedullin in monocytes and macrophages: possible involvement of macrophage-derived adrenomedullin in atherogenesis. Clin Sci (Lond) 97 (1999) 247-251
24. Nakazawa I., Nakajima T., Harada H., Ishigami T., Umemura S., and Emi M. Human calcitonin receptor-like receptor for adrenomedullin: genomic structure, eight single-nucleotide polymorphisms, and haplotype analysis. J Hum Genet 46 (2001) 132-136
25. Paigen B., Morrow A., Holmes P.A., Mitchell D., and Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68 (1987) 231-242
26. Pan C.S., Jiang W., Wu S.Y., Zhao J., Pang Y.Z., and Tang C.S. Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat. Basic Res Cardiol 101 (2006) 193-203
27. Pan C.S., Qi Y.F., Wu S.Y., Jiang W., Li G.Z., and Tang C.S. The role of adrenomedullin and its receptor system in cardiovascular calcification of rat induced by Vitamin D3 plus nicotine. Peptides 25 (2004) 601-608
28. Salonen R., and Salonen J.T. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 229 (1991) 225-231
29. Sata M., Kakoki M., Nagata D., Nishimatsu H., Suzuki E., Aoyagi T., et al. Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism. Hypertension 36 (2000) 83-88
30. Shinoki N., Kawasaki T., Minamino N., Okahara K., Ogawa A., Ariyoshi H., et al. Shear stress down-regulates gene transcription and production of adrenomedullin in human aortic endothelial cells. J Cell Biochem 71 (1998) 109-115
31. Shinomiya K., Ohmori K., Ohyama H., Hosomi N., Takahashi T., Osaka K., et al. Association of plasma adrenomedullin with carotid atherosclerosis in chronic ischemic stroke. Peptides 22 11 (2001) 1873-1880
32. Tsuruda T., and Burnett J.C. Adrenomedullin. An autocrine/paracrine factor for cardiorenal protection. Circ Res 90 (2002) 625-627
33. Tsuruda T., Kato J., Matsui E., Hatakeyama K., Masuyama H., Imamura T., et al. Adrenomedullin alleviates not only neointimal formation but also perivascular hyperplasia following arterial injury in rats. Eur J Pharmacol 508 1-3 (2005) 201-204
34. Udawela M., Hay D.L., and Sexton P.M. The receptor activity modifying protein family of G protein coupled receptor accessory proteins. Semin Cell Dev Biol 15 (2004) 299-308
35. Vaudo G., Marchesi S., Siepi D., Brozzetti M., Mannarino M.R., Pirro M., et al. Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries. Metabolism 56 (2007) 541-546
36. Wong L.Y., Cheung B.M., Li Y.Y., and Tang F. Adrenomedullin is both proinflammatory and antiinflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line. Endocrinology 146 (2005) 1321-1327
37. Yanagawa B., and Nagaya N. Adrenomedullin: molecular mechanisms and its role in cardiac disease. Amino Acids 32 (2007) 157-164
38. Yoshimoto T., Gochou N., Fukai N., Sugiyama T., Shichiri M., and Hirata Y. Adrenomedullin inhibits angiotensin II-induced oxidative stress and gene expression in rat endothelial cells. Hypertens Res 28 (2005) 165-172
39. Yoshimoto T., Fukai N., Sato R., Sugiyama T., Ozawa N., Shichiri M., et al. Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells. Endocrinology 145 (2004) 3331-3337
40. Zhang B., Tang C., Jiang Z., Qi Y., Pang Y., and Du J. Effects of adrenomedullin on vascular calcification in rats. Z Kardiol 91 (2002) 568-574
41. Zsuga J., Gesztelyi R., Torok J., Keki S., and Bereczki D. Asymmetric dimethylarginine: a molecule responsible for the coexistence of insulin resistance and atherosclerosis via dual nitric oxide synthase inhibition. Med Hypotheses 65 (2005) 1091-1098